Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gold Optical Enterprises (GOE) is a prominent medical device manufacturer specializing in the field of ophthalmology and contact lens technology. Based in Taiwan, the company is a global leader in the production of orthokeratology (Ortho-K) lenses, which are designed to temporarily reshape the cornea for vision correction without surgery. GOE's product portfolio includes a wide range of rigid gas permeable (RGP) lenses and specialty soft lenses tailored for myopia control and complex refractive errors. The company utilizes high-precision manufacturing processes and maintains international quality certifications to provide reliable optical solutions to eye care practitioners and patients worldwide. Their flagship products, such as the e-Lens series, are widely used in clinical practice for the management of progressive myopia in children and adolescents. GOE also engages in research and development to advance lens materials and designs for improved ocular health and comfort.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gold Optical Enterprises.